Govt Job for M.Pharm, M.Sc at Regional Centre for Biotechnology

Regional Centre for Biotechnology is an Institution of national importance established by the Department of Biotechnology, Govt. of India, with regional and global partnerships synergizing with the programmes of UNESCO.

The primary focus of RCB is to provide world class education, training and conduct innovative research at the interface of multiple disciplines to create high quality human resource in disciplinary and interdisciplinary areas of biotechnology in a globally competitive research milieu

Post : Project-JRF position – 01 Post

Title of Project : Deciphering the impact of Time-Restricted Feeding (TRF) as a Neoadjuvant Intervention with Chemotherapy for Cancer Treatment, and its Regulatory Mechanisms.

Duration : Upto 08.07.2022.

Essential Qualifications : M.Sc./MPharm with any National Level Test and experience in mass spectrometry.

Principal Investigator : Dr. Avinash Bajaj, Professor

Fellowship : Rs.31,000/- + 24% HRA per month.

Interested candidates should apply online by 22nd August, 2021, 5:00 PM. The shortlisted candidates will be informed by 25th August, 2021 via email to appear in the online interview to be held at 10:00 AM on 27th August, 2021.

For any query, you may contact PI by email: bajaj@rcb.res.in
Regional Centre for Biotechnology,
3rd Milestone, Faridabad-Gurgaon Expressway
NCR Biotech Science Cluster, Faridabad,
Faridabad (Haryana).

Related Posts

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Phase 2 results for LB-102 showed statistically significant reductions in PANSS total score across all doses with onset by week 1 and sustained through study end, alongside low rates of…

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

After substandard drug manufacturing, the state drug firms are once again under the scanner of the central government for manufacture and sale of unapproved fixed dose combination (FDC) drugs which…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise